IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 130 filers reported holding IVERIC BIO INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,181,128 | -58.5% | 55,443 | -74.3% | 0.00% | -66.7% |
| Q1 2023 | $5,256,715 | +51.0% | 216,059 | +30.9% | 0.00% | +50.0% |
| Q4 2022 | $3,481,341 | +36.5% | 165,005 | +13.3% | 0.00% | 0.0% |
| Q3 2022 | $2,549,567 | +54.0% | 145,654 | -15.0% | 0.00% | +100.0% |
| Q2 2022 | $1,655,215 | -42.7% | 171,287 | -2.5% | 0.00% | -50.0% |
| Q1 2022 | $2,890,998 | +206.9% | 175,694 | +208.1% | 0.00% | +100.0% |
| Q4 2021 | $942,000 | +9.7% | 57,016 | +7.8% | 0.00% | 0.0% |
| Q3 2021 | $859,000 | +159.5% | 52,912 | +0.8% | 0.00% | – |
| Q2 2021 | $331,000 | +16.5% | 52,515 | +14.2% | 0.00% | – |
| Q1 2021 | $284,000 | -15.2% | 45,980 | -5.1% | 0.00% | – |
| Q4 2020 | $335,000 | +30.9% | 48,473 | +7.0% | 0.00% | – |
| Q3 2020 | $256,000 | +70.7% | 45,304 | +61.6% | 0.00% | – |
| Q2 2020 | $150,000 | – | 28,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |